Pharma firm to create 200 jobs

The move marks the first time the biopharmaceutical company — which specialises in treatments for unmet medical needs — has ever built its own manufacturing and development site, with each of its existing facilities having been acquired or inherited.
Construction at the 55,000sq ft, 17-acre site in Monksland will begin immediately, with it expected to be fully operational by 2016.